ESG
Cardinal Health sets new benchmark in sustainability
In an era where sustainability has become a corporate buzzword, Jane Crowe, Managing Director of Cardinal Health ANZ, is pushing for real action.
In an exclusive podcast, she dissected the government’s climate commitments, the medtech industry’s sustainability roadblocks, and why Australia is at the heart of Cardinal Health’s next big move.
Last August, Assistant Health Minister Ged Kearney established an advisory group to address the health impacts of climate change, following the release of the National Health and Climate Strategy. But has it driven meaningful change, or is it yet another government talkfest?
Cardinal Health is making a game-changing move: its first remanufacturing facility outside the U.S. will be in Newcastle. But why Australia, and why now?
As a key member of the MTAA Sustainability Forum, Crowe is on the frontline of medtech’s sustainability challenges. The industry’s carbon footprint is massive, but slashing emissions isn’t as straightforward as it sounds. Supply chain complexities, regulatory hurdles, and reporting challenges all play a role in slowing progress.
With an election looming, Crowe didn’t hold back on what she wants from policymakers. She outlined a vision for a more climate-conscious future – one where sustainability isn’t an afterthought but a core business imperative.
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - Pharmaceuticals

Reform blueprint pushes for radical shift amid growing calls for political integrity and transparency
With the federal election now behind us, a bold reform blueprint is back on the table, calling for robust parliamentary […]
MoreNews & Trends - Pharmaceuticals

Australia to launch first guidelines in motor neurone disease
A two-year project to develop the nation’s first clinical guidelines for motor neurone disease (MND) has been launched by University […]
MoreNews & Trends - Pharmaceuticals

World-first immunotherapy trial to treat Type 1 diabetes
Australian researchers have dosed participants in the first clinical trial of an immunotherapy drug to treat Type 1 diabetes. Professor […]
MoreNews & Trends - MedTech & Diagnostics

Bridging the gap between invention and commercialisation for local medtechs
A new national push to get Australian-made medical technologies into local hospitals has been launched, aiming to close the long-standing […]
More